EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C17H14O4 |
| Net Charge | 0 |
| Average Mass | 282.295 |
| Monoisotopic Mass | 282.08921 |
| SMILES | Cc1ccc2c(=O)c3cccc(CC(=O)O)c3oc2c1C |
| InChI | InChI=1S/C17H14O4/c1-9-6-7-13-15(20)12-5-3-4-11(8-14(18)19)17(12)21-16(13)10(9)2/h3-7H,8H2,1-2H3,(H,18,19) |
| InChIKey | XGOYIMQSIKSOBS-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | Bronsted acid A molecular entity capable of donating a hydron to an acceptor (Brønsted base). |
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| vadimezan (CHEBI:75934) has role antineoplastic agent (CHEBI:35610) |
| vadimezan (CHEBI:75934) is a monocarboxylic acid (CHEBI:25384) |
| vadimezan (CHEBI:75934) is a xanthones (CHEBI:51149) |
| IUPAC Name |
|---|
| (5,6-dimethyl-9-oxo-9H-xanthen-4-yl)acetic acid |
| INNs | Source |
|---|---|
| vadimezan | ChemIDplus |
| vadimezan | WHO MedNet |
| vadimezanum | WHO MedNet |
| vadimézan | WHO MedNet |
| Synonyms | Source |
|---|---|
| (5,6-dimethyl-9-oxoxanthen-4-yl)acetic acid | ChEBI |
| Dimethyloxoxanthene acetic acid | ChemIDplus |
| 5,6-Dimethyl-9-oxo-9H-xanthene-4-acetic acid | ChemIDplus |
| NSC 640488 | ChemIDplus |
| AS 1404 | ChemIDplus |
| AS-1404 | ChemIDplus |
| Registry Numbers | Sources |
|---|---|
| Reaxys:4262852 | Reaxys |
| CAS:117570-53-3 | ChemIDplus |
| Citations |
|---|